Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells-Reference-Cited by-同舟云学术

Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

Published:2010-03-03 Issue:2 Volume:116 Page:73-78
ISSN:1381-3455
Container-title:Archives of Physiology and Biochemistry
language:en
Short-container-title:Archives of Physiology and Biochemistry

Author:

Mayer Doris,Chantelau Ernst

Publisher

Informa UK Limited

Subject

Physiology (medical),Physiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/13813451003631439

Reference30 articles.

1. Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay

2. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

3. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

4. Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers;Current Opinion in Pharmacology;2021-10

2. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients;Frontiers in Oncology;2021-01-28

4. Cancer Biology and Prevention in Diabetes;Cells;2020-06-02

5. ANALOGHI DELL’INSULINA E CANCRO;il Diabete;2019-03-15